Prasugrel [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2012-11-26 16:30 (4549 d 09:33 ago) – Posting: # 9593
Views: 17,344

Hi Łukasz!

❝ As per reference product SmPC prasugrel may be administered with or without food. Wchich means that in EU one study under fasting conditions would be sufficent.


True. But I don’t know whether Sam wants to apply in the EU.

❝ Based on fast study, Sam's formulation would be approved, although clearly it is not bioequivalent under fed conditions.


OK, for the FDA Sam would have to show BE fasting+fed. Even for EMA we have to show the synopsis of all studies performed during product development. Too bad that the Cmax ratio was that high in fed state. I would expect questions approaching.

❝ Taking this into consideration and this Helmut's statement:

❝ ❝ General remark: For the majority of formulations BE in fed state is more difficult to show than in fasted state.

❝ what rationale for this guideline wording:

"In general, a bioequivalence study should be conducted under fasting conditions as this is considered to be the most sensitive condition to detect a potential difference between formulations." is?

❝ In this case it looks like it is totally other way round.


I should have been more precise. EMA’s (and FDA’s) point of view generally is correct for most IR formulations. For MR formulations (more of the delayed release type) and IR formulations of drugs with presystemic metabolism and/or a high first pass (especially pro drugs), this might not be the case, IMHO.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
152 visitors (0 registered, 152 guests [including 4 identified bots]).
Forum time: 03:03 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5